Clinical Governance
The protocol was updated. The committee approved. No one stopped it.
Adverse outcomes appeared weeks later.
One question remains: who owned it while it was happening?
Clinical governance works until it meets reality.
Protocols are reviewed. Committees approve. Risk is documented.
Execution begins.
Then something shifts.
Not enough to trigger a rollback. Not clear enough to escalate. But no longer stable.
And still — it continues.
Not the protocol. Not the review process.
The failure is simpler.
So momentum decided.
And responsibility appeared only after harm.
Most healthcare systems know how to approve.
Almost none define, in advance, who owns a clinical pathway while it is actively unfolding under uncertainty.
Not who designed it. Not who reviewed it.
Stopping is not the end.
It is the beginning of a governance event.
Once a pathway is interrupted, five things must already be defined:
State
What is the system state after interruption. What continues. What is held.
Holder
One named individual. Not a role. Not a committee.
Time
How long the system may remain held before escalation is required.
Release
What conditions justify continuation. Not agreement. Written rationale.
Silence
What happens if no one responds.
It is exposed.
Decisions continue implicitly. Without ownership.
Until outcomes force attribution.
They fail in moments no one holds.
If no one owns the pathway while it is happening,
someone will be made to own it after.
Selective work with CMOs, Medical Directors, and clinical leadership.
Focus: irreversible decisions under uncertainty, and the point where governance becomes personal.
Inquiry only.
Begin Private Inquiry